The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Next generation probiotics in disease amelioration
Open accessAbstract
Studies on the role of gut commensal bacteria in health development have rapidly attracted much more attention beyond the classical pathogens over the last decade. Many important reports have highlighted the changes in the gut microbiota (dysbiosis) are closely related to development of intra- and extra-intestinal, chronic inflammation related diseases such as colitis, obesity/metabolic syndromes, diabetes mellitus, liver diseases, cardiovascular diseases and also cancer and neurodegenerative diseases. To circumvent these difficulties, the strategy of modulating the structure of the gut microbiota has been under intensive study and shed more light on amelioration of these inflammation related diseases. While traditional probiotics generally show marginal ameliorative effects, emerging next generation probiotics start to reveal as new preventive and therapeutic tools. Recent studies have unraveled many potential next generation probiotics (NGP). These include Prevotella copri and Christensenella minuta that control insulin resistance, Parabacteroides goldsteinii, Akkermansia muciniphila and Bacteroides thetaiotaomicron that reverse obesity and insulin resistance, Faecalibacterium prausnitzii that protects mice against intestinal diseases, and Bacteroides fragilis that reduces inflammation and shows anticancer effect. New agents will soon be revealed for targeted therapy on specific inflammation related diseases. The important roles of next generation probiotics and gut microbiota normobiosis on the maintenance of intestinal integrity and homeostasis are emphasized.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., et al. (2018) · Science · doi:10.1126/science.aan3706 · Cited by 5,671
Role of the microbiota in immunity and inflammation.
Belkaid, Y., & Hand, T. W. (2014) · Cell · doi:10.1016/j.cell.2014.03.011 · Cited by 5,385
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., et al. (2018) · Science · doi:10.1126/science.aan4236 · Cited by 4,812 · cited 3×
“[56] Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, et al.”
BackgroundCross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., Guiot, Y., Derrien, M., Muccioli, G. G., Delzenne, N. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219451110 · Cited by 4,511
Interactions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy
Sivan, A., Corrales, L., Hubert, N., Williams, J. B., Aquino-Michaels, K., Earley, Z. M., Benyamin, F. W., Man Lei, Y., Jabri, B., Alegre, M.-L., et al. (2015) · Science · doi:10.1126/science.aac4255 · Cited by 3,888 · cited 5×
“[28] Sivan A, Corrales L, Hubert N, Williams JB, AquinoMichaels K, Earley ZM, et al.”
BackgroundInfluentialHuman Genetics Shape the Gut Microbiome
Goodrich, J. K., Waters, J. L., Poole, A. C., Sutter, J. L., Koren, O., Blekhman, R., Beaumont, M., Van Treuren, W., Knight, R., Bell, J. T., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.053 · Cited by 3,164 · cited 4×
“minuta also shows potential probiotic effects against obesity and associated metabolic disorders [50].”
BackgroundInfluentialPathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
Mogensen, T. H. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00046-08 · Cited by 3,111
The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients
Matson, V., Fessler, J., Bao, R., Chongsuwat, T., Zha, Y., Alegre, M.-L., Luke, J. J., & Gajewski, T. F. (2018) · Science · doi:10.1126/science.aao3290 · Cited by 3,107 · cited 1×
“[64] Matson V, Fessler J, Bao R, Chongsuwat T, Zha Y, Alegre ML, et al.”
BackgroundRound, J. L., & Mazmanian, S. K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909122107 · Cited by 2,233
Plovier, H., Everard, A., Druart, C., Depommier, C., Van Hul, M., Geurts, L., Chilloux, J., Ottman, N., Duparc, T., Lichtenstein, L., et al. (2017) · Nature Medicine · doi:10.1038/nm.4236 · Cited by 2,204
Peng, L., Li, Z.-R., Green, R. S., Holzmanr, I. R., & Lin, J. (2009) · The Journal of Nutrition · doi:10.3945/jn.109.104638 · Cited by 2,130
Human gut microbes impact host serum metabolome and insulin sensitivity
Pedersen, H. K., Gudmundsdottir, V., Nielsen, H. B., Hyotylainen, T., Nielsen, T., Jensen, B. A. H., Forslund, K., Hildebrand, F., Prifti, E., Falony, G., et al. (2016) · Nature · doi:10.1038/nature18646 · Cited by 2,116 · cited 3×
“[36] Pedersen HK, Gudmundsdottir V, Nielsen HB, Hyotylainen T, Nielsen T, Jensen BA, et al.”
BackgroundInfluentialHuman gut microbiome: Hopes, threats and promises
Cani, P. D. (2018) · Gut · doi:10.1136/gutjnl-2018-316723 · Cited by 1,386
Chaput, N., Lepage, P., Coutzac, C., Soularue, E., Le Roux, K., Monot, C., Boselli, L., Routier, E., Cassard, L., Collins, M., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx108 · Cited by 1,310
Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota
Chang, C.-J., Lin, C.-S., Lu, C.-C., Martel, J., Ko, Y.-F., Ojcius, D. M., Tseng, S.-F., Wu, T.-R., Chen, Y.-Y. M., Young, J. D., et al. (2015) · Nature Communications · doi:10.1038/ncomms8489 · Cited by 1,249
Self-citationFaecalibacterium prausnitzii and human intestinal health
Miquel, S., Martín, R., Rossi, O., Bermúdez-Humarán, L., Chatel, J., Sokol, H., Thomas, M., Wells, J., & Langella, P. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.06.003 · Cited by 1,228
Microbiota-activated PPAR-γ signaling inhibits dysbiotic Enterobacteriaceae expansion
Byndloss, M. X., Olsan, E. E., Rivera-Chávez, F., Tiffany, C. R., Cevallos, S. A., Lokken, K. L., Torres, T. P., Byndloss, A. J., Faber, F., Gao, Y., et al. (2017) · Science · doi:10.1126/science.aam9949 · Cited by 1,215
Minireview: Gut microbiota: The neglected endocrine organ
Clarke, G., Stilling, R. M., Kennedy, P. J., Stanton, C., Cryan, J. F., & Dinan, T. G. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1108 · Cited by 1,192
Kelly, J. R., Kennedy, P. J., Cryan, J. F., Dinan, T. G., Clarke, G., & Hyland, N. P. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00392 · Cited by 1,110 · cited 2×
“This is followed by abrogation of intestinal integrity, leading to leaky gut phenomena and occurrence of chronic inflammations-related diseases [8].”
BackgroundNext-Generation Beneficial Microbes: The Case of Akkermansia muciniphila
Cani, P. D., & de Vos, W. M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01765 · Cited by 1,058
Genetic determinants of the gut microbiome in UK twins
Goodrich, J. K., Davenport, E. R., Beaumont, M., Jackson, M. A., Knight, R., Ober, C., Spector, T. D., Bell, J. T., Clark, A. G., & Ley, R. E. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.04.017 · Cited by 1,048
Daillère, R., Vétizou, M., Waldschmitt, N., Yamazaki, T., Isnard, C., Poirier-Colame, V., Duong, C. P. M., Flament, C., Lepage, P., Roberti, M. P., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.09.009 · Cited by 897
Wrzosek, L., Miquel, S., Noordine, M.-L., Bouet, S., Chevalier-Curt, M. J., Robert, V., Philippe, C., Bridonneau, C., Cherbuy, C., Robbe-Masselot, C., et al. (2013) · BMC Biology · doi:10.1186/1741-7007-11-61 · Cited by 804
Schneeberger, M., Everard, A., Gómez-Valadés, A. G., Matamoros, S., Ramírez, S., Delzenne, N. M., Gomis, R., Claret, M., & Cani, P. D. (2015) · Scientific Reports · doi:10.1038/srep16643 · Cited by 798
Wu, T.-R., Lin, C.-S., Chang, C.-J., Lin, T.-L., Martel, J., Ko, Y.-F., Ojcius, D. M., Lu, C.-C., Young, J. D., & Lai, H.-C. (2019) · Gut · doi:10.1136/gutjnl-2017-315458 · Cited by 758
Self-citationMicrobiota-Produced Succinate Improves Glucose Homeostasis via Intestinal Gluconeogenesis
De Vadder, F., Kovatcheva-Datchary, P., Zitoun, C., Duchampt, A., Bäckhed, F., & Mithieux, G. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.06.013 · Cited by 754
Duncan, S. H., Hold, G. L., Harmsen, H. J. M., Stewart, C. S., & Flint, H. J. (2002) · International Journal of Systematic and Evolutionary Microbiology · doi:10.1099/00207713-52-6-2141 · Cited by 708
Tlaskalová-Hogenová, H., Štěpánková, R., Kozáková, H., Hudcovic, T., Vannucci, L., Tučková, L., Rossmann, P., Hrnčíř, T., Kverka, M., Zákostelská, Z., et al. (2011) · Cellular & Molecular Immunology · doi:10.1038/cmi.2010.67 · Cited by 693
Hiippala, K., Jouhten, H., Ronkainen, A., Hartikainen, A., Kainulainen, V., Jalanka, J., & Satokari, R. (2018) · Nutrients · doi:10.3390/nu10080988 · Cited by 594
GPCR-Mediated Signaling of Metabolites
Husted, A. S., Trauelsen, M., Rudenko, O., Hjorth, S. A., & Schwartz, T. W. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.03.008 · Cited by 590
Heintz‐Buschart, A., Pandey, U., Wicke, T., Sixel‐Döring, F., Janzen, A., Sittig‐Wiegand, E., Trenkwalder, C., Oertel, W. H., Mollenhauer, B., & Wilmes, P. (2018) · Movement Disorders · doi:10.1002/mds.27105 · Cited by 554
Intestinal Commensal Microbes as Immune Modulators
Ivanov, I. I., & Honda, K. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.09.009 · Cited by 425
Taxonomy of Lactobacilli and Bifidobacteria.
Felis, G. E., & Dellaglio, F. (2007) · PubMed · Cited by 326
Taxonomy of lactobacilli and bifidobacteria.
Dellaglio, F., & Felis, G. E. (2005) · Cited by 323
The SCFA Receptor GPR43 and Energy Metabolism
Kimura, I., Inoue, D., Hirano, K., & Tsujimoto, G. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00085 · Cited by 296
Dasgupta, S., Erturk-Hasdemir, D., Ochoa-Reparaz, J., Reinecker, H.-C., & Kasper, D. L. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.03.006 · Cited by 292
Bacteroides fragilis Lipopolysaccharide and Inflammatory Signaling in Alzheimer’s Disease
Lukiw, W. J. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01544 · Cited by 288
The Intestinal Microbiota in Metabolic Disease
Woting, A., & Blaut, M. (2016) · Nutrients · doi:10.3390/nu8040202 · Cited by 284
Metabolic activities and probiotic potential of bifidobacteria
Russell, D. A., Ross, R. P., Fitzgerald, G. F., & Stanton, C. (2011) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2011.06.003 · Cited by 267
The contribution of culturomics to the repertoire of isolated human bacterial and archaeal species
Bilen, M., Dufour, J.-C., Lagier, J.-C., Cadoret, F., Daoud, Z., Dubourg, G., & Raoult, D. (2018) · Microbiome · doi:10.1186/s40168-018-0485-5 · Cited by 231
Le Leu, R. K., Hu, Y., Brown, I. L., Woodman, R. J., & Young, G. P. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp197 · Cited by 206
Park, Y.-J., Kuen, D.-S., & Chung, Y. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0130-1 · Cited by 194
Oxygen metabolism and barrier regulation in the intestinal mucosa
Glover, L. E., Lee, J. S., & Colgan, S. P. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84429 · Cited by 169
The human commensal Bacteroides fragilis binds intestinal mucin
Huang, J. Y., Lee, S. M., & Mazmanian, S. K. (2011) · Anaerobe · doi:10.1016/j.anaerobe.2011.05.017 · Cited by 166
Actualización de probióticos, prebióticos y simbióticos en nutrición clínica
Olveira, G., & González-Molero, I. (2016) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2016.07.006 · Cited by 161
Probiotics in colorectal cancer (CRC) with emphasis on mechanisms of action and current perspectives
Kahouli, I., Tomaro-Duchesneau, C., & Prakash, S. (2013) · Journal of Medical Microbiology · doi:10.1099/jmm.0.048975-0 · Cited by 159
Association of EnterotoxigenicBacteroides fragilisInfection with Inflammatory Diarrhea
Sears, C. L., Islam, S., Saha, A., Jamil, M., Alam, N. H., Faruque, S. M., Salam, M. A., Shin, J. W., Hecht, D. W., Weintraub, A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/591130 · Cited by 155
Impact of the gut microbiota, prebiotics, and probiotics on human health and disease
Lai, H.-C., Young, J., Lin, C.-S., Chang, C.-J., Lu, C.-C., Martel, J., Ojcius, D., & Ko, Y.-F. (2014) · Biomedical Journal · doi:10.4103/2319-4170.138314 · Cited by 153 · cited 2×
“[3] Lin CS, Chang CJ, Lu CC, Martel J, Ojcius DM, Ko YF, et al.”
BackgroundSelf-citationGlucose metabolism: Focus on gut microbiota, the endocannabinoid system and beyond
Cani, P. D., Geurts, L., Matamoros, S., Plovier, H., & Duparc, T. (2014) · Diabetes & Metabolism · doi:10.1016/j.diabet.2014.02.004 · Cited by 151
Omics of bifidobacteria: research and insights into their health-promoting activities
Bottacini, F., van Sinderen, D., & Ventura, M. (2017) · Biochemical Journal · doi:10.1042/bcj20160756 · Cited by 138
Roller, M., Clune, Y., Collins, K., Rechkemmer, G., & Watzl, B. (2007) · British Journal of Nutrition · doi:10.1017/s0007114507450292 · Cited by 125 · cited 2×
“[31] Roller M, Clune Y, Collins K, Rechkemmer G, Watzl B.”
BackgroundAn update on probiotics, prebiotics and symbiotics in clinical nutrition
Olveira, G., & González-Molero, I. (2016) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2016.10.011 · Cited by 102
Fu, G., Li, X., Hou, Y., Fan, Y., Liu, W., & Xu, G. (2004) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700758 · Cited by 91
Kanauchi, O. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i7.1071 · Cited by 78
Derosa, L., Routy, B., Kroemer, G., & Zitvogel, L. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1434468 · Cited by 74
Ertürk-Hasdemir, D., & Kasper, D. L. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13660 · Cited by 74
Wang, Y., Ma, R., Liu, F., Lee, S. A., & Zhang, L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00374 · Cited by 71
Targeting pattern-recognition receptors to discover new small molecule immune modulators
Zhu, G., Xu, Y., Cen, X., Nandakumar, K. S., Liu, S., & Cheng, K. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.12.026 · Cited by 68
Pitt, J. M., Vétizou, M., Boneca, I. G., Lepage, P., Chamaillard, M., & Zitvogel, L. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1132137 · Cited by 66
Distribution‐free Partially Sequential Tests for Treatments Versus Control Setting
Kim, D., & Wolfe, D. A. (1995) · Biometrical Journal · doi:10.1002/bimj.4710370302 · Cited by 60
Rong, Y., Dong, Z., Hong, Z., Jin, Y., Zhang, W., Zhang, B., Mao, W., Kong, H., Wang, C., Yang, B., et al. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.07.009 · Cited by 59
Delcenserie, V., Gavini, F., Beerens, H., Tresse, O., Franssen, C., & Daube, G. (2007) · Systematic and Applied Microbiology · doi:10.1016/j.syapm.2007.01.004 · Cited by 55
The role of the immune system in regulating the microbiota
Willing, B. P., Gill, N., & Finlay, B. B. (2010) · Gut Microbes · doi:10.4161/gmic.1.4.12520 · Cited by 54
Bourafa, N., Loucif, L., Boutefnouchet, N., & Rolain, J. (2015) · New Microbes and New Infections · doi:10.1016/j.nmni.2015.08.003 · Cited by 49
Guo, H., Diao, N., Yuan, R., Chen, K., Geng, S., Li, M., & Li, L. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1500130 · Cited by 42
Osamu, Kanauchi, Masanobu, Fukuda, Yoshiaki, Matsumoto, Shino, Ishii, I., Toyokazu, Ozawa, et al. (2006) · Acta Scientiarum Naturalium Universitatis Sunyatseni · Cited by 36
Considerations in the Development of Live Biotherapeutic Products for Clinical Use
Ross, J. J., Boucher, P. E., Bhattacharyya, S. P., Kopecko, D. J., Sutkowski, E. M., Rohan, P., Chandler, D. K. F., & Vaillancourt, J. (2008) · Current Issues in Molecular Biology · doi:10.21775/cimb.010.013 · Cited by 23
Allogeneic stem cell transplantation for HIV-positive patients with hematologic malignancies
Mulanovich, V. E., Desai, P. A., & Popat, U. (2016) · AIDS · doi:10.1097/qad.0000000000001240 · Cited by 21
Cited by
The human gut bacteria Christensenellaceae are widespread, heritable, and associated with health
Waters, J. L., & Ley, R. E. (2019) · BMC Biology · doi:10.1186/s12915-019-0699-4 · Cited by 798
Immunosenescence and inflammaging in the aging process: age-related diseases or longevity?
Santoro, A., Bientinesi, E., & Monti, D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101422 · Cited by 603
Polyphenol-Mediated Gut Microbiota Modulation: Toward Prebiotics and Further
Rodríguez-Daza, M. C., Pulido-Mateos, E. C., Lupien-Meilleur, J., Guyonnet, D., Desjardins, Y., & Roy, D. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.689456 · Cited by 474
Lai, H.-C., Lin, T.-L., Chen, T.-W., Kuo, Y.-L., Chang, C.-J., Wu, T.-R., Shu, C.-C., Tsai, Y.-H., Swift, S., & Lu, C.-C. (2022) · Gut · doi:10.1136/gutjnl-2020-322599 · Cited by 331
Self-citationTryptophan Metabolism as a Pharmacological Target
Modoux, M., Rolhion, N., Mani, S., & Sokol, H. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.11.006 · Cited by 284
Metadata
- Authors
- Chang, C.-J., Lin, T.-L., Tsai, Y.-L., Wu, T.-R., Lai, W.-F., Lu, C.-C., & Lai, H.-C.
- Venue
- Journal of Food and Drug Analysis
- Published
- 2019-07
- Volume
- 27
- Issue
- 3
- Pages
- 615-622
- ISSN
- 1021-9498 (ISSN-L)
- OpenAlex
- W2911733907
- Cited by
- 369
- References
- 69
- FWCI
- 11.17
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.